本頁面由Tiger Trade Technology Pte. Ltd.提供服務

中嘉國際

0.380
0.000
成交量:- -
成交額:- -
市值:1,204.60萬
市盈率:6.33
高:0.380
開:0.380
低:0.380
收:0.380
52周最高:0.605
52周最低:0.335
股本:3,170.00萬
流通股本:677.08萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):0.060
每股收益(LYR):0.051
淨資產收益率:18.14%
總資產收益率:2.64%
市淨率:1.09
市盈率(LYR):7.48

資料載入中...

公司資料

公司名字:
中嘉國際
交易所:
SGX
成立時間:
1996
員工人數:
1096
公司地址:
5 Kallang Sector,#03-02,Singapore,Singapore
郵編:
349279
電話:
傳真:
65 6743 7916
簡介:
Pharmesis International Ltd. is a Singapore-based investment holding company. The Company is a pharmaceutical company engaged in the manufacturing of pharmaceutical products, including western medicine in the form of tablets and granules, among others, and traditional Chinese medicine (TCM) formulated products for the treatment of illnesses relating to the liver and gall bladder. It operates in three segments: Western drugs, which refers mainly to chemically formulated drugs marketed under the Kinna brand; TCM formulated drugs, which includes TCM marketed under the Longlife brand, and Distribution, which includes agency products and internally manufactured products marketed through the distribution arm. Its main products are ATT, Gulin Gansu and Er Ding granules. Its subsidiary, Chengdu Kinna Pharmaceutical Co., Ltd, is engaged in the development, manufacture, packaging and sale of western medicines and health tonic products.